What is the current stock price of Wag! Group Co. (PET)?

As of the latest market data, Wag! Group Co. (PET) is trading at $0.05. The stock has seen a loss of 0.00% today.

Does Wag! Group Co. (PET) pay a dividend?

Based on current data, Wag! Group Co. does not have a confirmed active dividend policy.

What is the market cap of Wag! Group Co.?

The current market capitalization of Wag! Group Co. (PET) is approximately unavailable.

PET

Wag! Group Co.·Technology

0.05

0.000%(+0.00)

Market Open

Last Updated: — ET

52W L: $0.0052W H: $1.16

PET NEWS

globenewswire.com

5d ago

AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS

AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS Presentation at 2026 TDP43 Summit shows ACI-19626 detects TDP-43 pathology in patients with amyotrophic lateral sclerosis (ALS) Previously reported data also showed detection of TDP-43 in patients with genetically defined frontotemporal dementia (FTD) Underlines potential for precision medicine enabling early diagnosis and intervention in multiple neurodegenerative diseases Lausanne, Switzerland, May 22, 2026 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced the presentation of new preliminary data from a Phase 1 trial of its first-in-class TDP-43 positron emission tomography (PET) tracer ACI-19626 showing increased uptake in the brains of patients with amyotrophic lateral sclerosis (ALS). The results presented at the 2026 TDP43 Summit in Madison, Wisconsin, demonstrate that PET scans with ACI-19626 showed tracer uptake significantly higher in key regions of the brain in patients with ALS compared to healthy controls.

globenewswire.com

May 20

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer's Clinical Trial at 2nd NovaScan Location Planned for Tampa

VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with Catalyst MedTech (Catalyst), to provide a minimum of 200 brain Positron Emission Tomography (PET) scans for an upcoming Alzheimer's Disease (AD) clinical trial, to be conducted by an international Contract Research Organization (CRO) specializing in AD research. The PET Scans will be performed at the Company's NovaScan Neuroimaging Clinics™ second location planned for Tampa, Florida.

globenewswire.com

May 15

Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches

MELBOURNE, Australia and INDIANAPOLIS, May 15, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that it has entered into letters of intent to pursue collaborations with EDAP TMS S.A. (NASDAQ: EDAP, “EDAP”) and Profound Medical Corp. (NASDAQ: PROF, TSX: PRN, “Profound”), leading companies developing advanced minimally invasive and image-guided treatment ablative technologies for prostate cancer, including focal, subtotal, and whole-gland treatment approaches. These initiatives reflect Telix's commitment to advancing the integration of molecular imaging into the evolving prostate cancer treatment landscape to help inform clinical decision-making.

globenewswire.com

May 12

Pet Valu Announces Election of Directors

MARKHAM, Ontario, May 12, 2026 (GLOBE NEWSWIRE) -- Pet Valu Holdings Ltd. (“Pet Valu” or the “Company”) (TSX: PET) announced at its Annual General Meeting of Shareholders (the “Meeting”) held today that all of the director nominees set out in the Company's Management Information Circular dated March 17, 2026, were elected as directors of Pet Valu.

seekingalpha.com

May 12

Pet Valu Holdings Ltd. (PET:CA) Shareholder/Analyst Call Prepared Remarks Transcript

seekingalpha.com

May 12

Pet Valu Holdings Ltd. (PET:CA) Q1 2026 Earnings Call Transcript

Company Profile

Wag! Group Co. develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent pet caregivers to connect with pet parents. Its platform allows pet parents, who require specific pet care services, such as dog walking, pet sitting and boarding, advice from licensed pet experts, home visits, training, and access to other services. The company was founded in 2015 and is based in Purchase, New York.

Sector

Technology

Industry

Software - Application

Employees

IPO Date

2021-09-27

Beta

1.26

Websitewww.wagwalking.com↗